in GIOP. We conditionally recommend PTH/PTHrP over anti-resorptives in patients at very high risk of fracture. We conditionally recommend DEN $& or PTH/PTHrP over oral and IV BP in high risk of fracture. We conditionally recommend IV BP, ROM, RAL over no treatment in high and very high risk of fracture. In moderate risk, we conditionally recommend BP, DEN, or PTH/PTHrP in no preferred order among these agents. Except in patients intolerant of other agents, we conditionally recommend against RAL